Is a bird flu vaccine for chickens coming soon?
Zoetis was granted a conditional license for its avian influenza vaccine for use in chickens. It's a step closer to fighting the bird flu outbreaks that continue to devastate flocks.
Company says it received conditional approval for bird flu vaccine from US Department of Agriculture
The US Department of Agriculture last week issued a conditional license for an avian flu vaccine for use in chickens, as an outbreak of a newer variant ravages poultry flocks, contributing to the sky high price of eggs.
As Bird Flu Outbreak Worsens, Zoetis Gets Green Light for Poultry Vaccine
TUESDAY, Feb. 18, 2025 (HealthDay News) -- The U.S. Department of Agriculture (USDA) has granted conditional approval for a new bird flu vaccine for poultry. This new avian flu vaccine, developed by New Jersey-based Zoetis, was approved last week after meeting safety and efficacy standards.
Bird flu vaccine gets ‘conditional license’ from USDA, company announces
A New Jersey pharmaceutical company has received a “a conditional license" for its bird flu vaccine for use in chickens. An infectious diseases expert comments.
Zoetis gets Conditional License for Bird Flu Vaccine
Zoetis has been granted a conditional license from the USDA for its avian flu vaccine. Since February 2022, more than 150 million birds have been affected in the US, causing egg prices to surge to all-time highs.
Zoetis Inc. stock underperforms Friday when compared to competitors despite daily gains
This was the stock's third consecutive day of gains.
A Once-in-a-Decade Opportunity: 1 Magnificent S&P 500 Dividend Stock Down 36% to Double Up on Right Now
A perfect example of this combination today is animal healthcare specialist Zoetis (NYSE: ZTS). Whether helping our furry ...
Greenwich Time on MSN3h
Greenwich Academy's 2025 commencement speaker is the CEO of animal health company Zoetis
Greenwich Academy's 2025 commencement speaker is Kristin Coveny Peck, the CEO of Zoetis, an animal health company.
Zoetis: In-Line Q4 Earnings And Weak Guidance Present A Buying Opportunity
Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance. Click here to find ...
Why Zoetis Stock Took Another Tumble Today
Zoetis slightly topped analyst estimates for profitability and met those for revenue in its fourth quarter. But as investors ...
Zoetis Avian Influenza Vaccine Secures Conditional Approval In US For Use In Chickens
Zoetis received a USDA conditional license for its H5N2 avian flu vaccine for chickens, marking a step in addressing the ...
Zoetis projects 6%-8% organic revenue growth for 2025 with strong companion animal performance
Q4 2024 Management View CEO Kristin Peck highlighted Zoetis delivered an excellent 2024, achieving double-digit operational revenue growth of 11% and adjusted net income growth of 15%. U.S. and ...
Zoetis Earnings Top Analysts' Forecasts
Zoetis exceeded market expectations in Q4 2024, with impressive financial performance despite challenges in specific segments ...